Suppr超能文献

评估非酒精性脂肪性肝病在严重和病态肥胖中的非侵入性检测的可行性和准确性。

Evaluating feasibility and accuracy of non-invasive tests for nonalcoholic fatty liver disease in severe and morbid obesity.

机构信息

Centre for Obesity Research and Education, Central Clinical School, Monash University, Melbourne, Australia.

Department of General Surgery, The Alfred Hospital, Melbourne, Australia.

出版信息

Int J Obes (Lond). 2018 Nov;42(11):1900-1911. doi: 10.1038/s41366-018-0007-3. Epub 2018 Jan 30.

Abstract

INTRODUCTION

In obese individuals, nonalcoholic fatty liver disease (NAFLD) is common but often goes undiagnosed, and therefore untreated. The presence of significant fibrosis is a key determinant of NAFLD progression, and liver steatosis has substantial cardiovascular implications. We aimed to determine the diagnostic accuracy of common noninvasive diagnostic tests for steatosis and fibrosis in the obese.

METHODS

We recruited 182 severely and morbidly obese individuals undergoing bariatric surgery (age 44 ± 12 years, body mass index 45.1 ± 8.3 kg/m). Medical history, blood tests and liver biopsy were taken on the day of surgery. Serum steatosis and fibrosis scores were calculated. In a subgroup of patients, transient elastography with controlled attenuation parameter (TE/CAP) (n = 82) and proton magnetic resonance spectroscopy (H-MRS) (n = 49) were performed.

RESULTS

H-MRS had excellent diagnostic accuracy for steatosis, with strong correlation to steatosis (r = 0.647, p < 0.001), good AUROC (0.852, p = 0.001), sensitivity (81.3%) and specificity (87.5%). However, due to low feasibility in this cohort (65.3% success), this was substantially decreased with intention-to-diagnose analysis (sensitivity 50.0%, specificity 60.9%). CAP had good feasibility (80.5%), and performed better in intention-to-diagnose analysis (AUROC 0.688, sensitivity 84.8%, specificity 47.2%). Serum steatosis scores performed poorly, with comparable accuracy to ALT. For significant fibrosis, TE had the best accuracy (AUROC 0.903, p = 0.007), which remained reasonable after intention-to-diagnose analysis (sensitivity 100%, specificity 59.0%). A combination approach using CAP with ALT for steatosis and TE with Forn index for fibrosis yielded reasonable overall accuracy.

CONCLUSIONS

H-MRS and TE/CAP had greatest accuracy for NAFLD-related steatosis and fibrosis. Failure rates in obesity significantly diminished diagnostic ability. Use of a combination of serum and imaging tests improved overall feasibility of assessment and diagnostic accuracy in obese individuals.

摘要

简介

在肥胖人群中,非酒精性脂肪性肝病(NAFLD)很常见,但往往未被诊断出来,因此也未得到治疗。显著纤维化的存在是非酒精性脂肪性肝病进展的关键决定因素,而肝脏脂肪变性对心血管有重大影响。我们旨在确定常用的非侵入性诊断试验对肥胖人群中脂肪变性和纤维化的诊断准确性。

方法

我们招募了 182 名接受减重手术的严重和病态肥胖个体(年龄 44±12 岁,体重指数 45.1±8.3kg/m2)。在手术当天采集病史、血液检查和肝活检。计算血清脂肪变性和纤维化评分。在患者亚组中,对 82 名患者进行了瞬时弹性成像伴受控衰减参数(TE/CAP)(n=82)和质子磁共振波谱(H-MRS)(n=49)。

结果

H-MRS 对脂肪变性具有出色的诊断准确性,与脂肪变性有很强的相关性(r=0.647,p<0.001),AUROC 良好(0.852,p=0.001),灵敏度(81.3%)和特异性(87.5%)。然而,由于该队列中可行性较低(65.3%的成功率),在意向诊断分析中显著降低(灵敏度 50.0%,特异性 60.9%)。CAP 具有良好的可行性(80.5%),并且在意向诊断分析中表现更好(AUROC 0.688,灵敏度 84.8%,特异性 47.2%)。血清脂肪变性评分表现不佳,与 ALT 的准确性相当。对于显著纤维化,TE 的准确性最高(AUROC 0.903,p=0.007),在意向诊断分析后仍然合理(灵敏度 100%,特异性 59.0%)。使用 CAP 联合 ALT 评估脂肪变性和 TE 联合 Forn 指数评估纤维化的联合方法可获得合理的整体准确性。

结论

H-MRS 和 TE/CAP 对 NAFLD 相关脂肪变性和纤维化具有最高的准确性。肥胖症的失败率显著降低了诊断能力。使用血清和影像学检查的组合可提高肥胖个体评估和诊断准确性的整体可行性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验